| Literature DB >> 35170075 |
Fazila Aloweni1, Stéphane L Bouchoucha2, Ana Hutchinson3, Shin Yuh Ang1, Hui Xian Toh1, Nur' Azzah Bte Suhari1, Raden Nurheryany Bte Sunari1, Siew Hoon Lim1.
Abstract
AIM: One of the greatest challenges in responding to the COVID-19 pandemic is preventing staff exposure and infection by ensuring consistent and effective use of personal protective equipment (PPE). This study explored health care workers' experience of prolonged PPE use in clinical practice settings and their concerns regarding PPE supply, effectiveness and training needs.Entities:
Keywords: acute care; health care workers; nurse; pressure injuries; protective personal equipment; side effect; skin tear
Mesh:
Year: 2022 PMID: 35170075 PMCID: PMC9111733 DOI: 10.1111/jan.15164
Source DB: PubMed Journal: J Adv Nurs ISSN: 0309-2402 Impact factor: 3.057
Comparison of demographic, clinical characteristics and hours of PPE use between participants with and without PPE‐related side effects (N = 592)
| Gender | Experience of PPE‐related side effects, | No experience of PPE‐related side effects, | Total ( |
|
|
|---|---|---|---|---|---|
| Male | 42 (13.1%) | 59 (21.6%) | 101 (17.1%) | 7.29 | .03 |
| Female | 273 (85.6%) | 212 (77.7%) | 485 (81.9%) | ||
| Prefer not to say | 4 (1.3%) | 2 (0.7%) | 6 (1.0%) | ||
| Age | |||||
| <21 | 3 (0.9%) | 3 (1.5%) | 6 (1%) | 16.06 | .07 |
| 21–30 | 130 (40.8%) | 91 (33.3%) | 222 (37.5%) | ||
| 31–40 | 126 (39.5%) | 94 (34.4%) | 220 (37.2%) | ||
| 41–50 | 32 (10.0%) | 35 (12.8%) | 67 (11.3%) | ||
| 51–60 | 20 (6.3%) | 30 (11.0%) | 50 (8.4%) | ||
| ≥61 | 8 (2.5%) | 19 (7.0%) | 27 (4.6%) | ||
| Occupation | |||||
| Doctor | 14 (4.4%) | 11 (4.0%) | 25 (4.2%) | 5.84 | .21 |
| Nurse | 282 (88.4%) | 235 (86.1%) | 517 (87.3%) | ||
| Allied health | 8 (2.5%) | 6 (2.2%) | 14 (2.4%) | ||
| Others | 15 (4.7%) | 21 (7.7%) | 36 (6.1%) | ||
| Work Location | |||||
| COVID‐19 isolation ward | 44 (13.8%) | 19 (7.0%) | 63 | 8.47 | <.001 |
| Acute respiratory infection ward | 71 (22.3%) | 26 (9.5%) | 97 | 17.93 | <.001 |
| Non‐acute respiratory ward | 76 (23.8%) | 134 (49.1%) | 210 | 21.31 | <.001 |
| Emergency Department | 126 (39.5%) | 84 (30.8%) | 210 | 5.07 | .02 |
| Operating theatre | 9 (2.8%) | 6 (2.2%) | 15 | 0.34 | .56 |
| Community isolation facilities | 22 (6.8%) | 19 (7.0%) | 41 | 0.001 | .98 |
| Others (including outpatient clinics) | 45 (14.1%) | 10 (3.7%) | 55 | 0.07 | .97 |
| Skin conditions | |||||
| None | 185 (58.0%) | 138 (50.5%) | 323 | 36.77 | <.001 |
| Yes | 134 (42.0%) | 135 (49.5%) | 269 | ||
| Eczema | 64 (47.8%) | 28 (10.3%) | 92 | ||
| Atopic dermatitis | 52 (38.8%) | 11 (4.0%) | 63 | ||
| Heat Rash | 46 (34.3%) | 6 (2.2%) | 52 | ||
| Dermatosis | 4 (3.0%) | 3 (1.1%) | 7 | ||
| Psoriasis | 7 (5.2%) | 1 (0.4%) | 8 | ||
| Dry skin | 104 (77.6%) | 52 (19.0%) | 156 | ||
| Others (Acne, Hives and Keloid) | 21 (15.7%) | 7 (2.6%) | 28 | ||
| Hours of PPE use (hours)/shift, mean ( | 6.80 (0.39) | 5.37 (4.21) | 6.14 (5.85) | −2.99 | <.003 |
Significant value p < .05.
Chi‐square test.
Independent two‐sample t‐test.
Data expressed denotes multiple responses.
Factors associated with the development of PPE‐related side effects
| Gender | Adjusted OR (95% CI) |
|
|---|---|---|
| Male | Ref | .003 |
| Female | 2.10 (1.29–3.42) | |
| Age | ||
| ≤30 | Ref | |
| 31 to 50 | 0.76 (0.51–1.12) | .16 |
| ≥51 | 0.40 (0.22–0.72) | .002 |
| Occupation | ||
| Doctor | Ref | |
| Nurse | 0.98 (0.39–2.49) | .97 |
| Allied health | 0.96 (0.20–4.50) | .95 |
| Others | 0.70 (0.23–2.20) | .55 |
| Work location | ||
| Low risk | Ref | |
| High risk | 3.12 (2.17–4.60) | <.001 |
| Skin conditions | ||
| No | Ref | |
| Yes | 0.33 (0.23–0.47) | <.001 |
Significant value p < .05.
No PPE and other medical device related side effects is the reference group.
Non‐acute respiratory wards, outpatient clinics, operating theatre and others.
Isolation wards and community isolation facilities, acute respiratory wards and DEM.
Impact of PPE‐related side effects on daily work (N = 319)
| Types of PPE ( | Goggles | Face shield | N95 mask | Surgical/reusable mask |
|
|
|---|---|---|---|---|---|---|
| Side effects | ||||||
| Burning/pain | 51 (16.0%) | 12 (3.8%) | 78 (24.5%) | 8 (2.5%) | 184.58 | <.001 |
| Pressure injuries | 103 (32.3%) | 16 (5%) | 146 (45.8%) | 12 (3.8%) | ||
| Skin tear | 14 (4.4%) | 2 (0.6%) | 45 (14.1%) | 5 (1.6%) | ||
| Blister | 15 (4.7%) | 3 (0.9%) | 28 (8.8%) | 2 (0.6%) | ||
| Eye protection inducted acne | 36 (11.3%) | 10 (3.1%) | — | — | ||
| Mask induced acne | 1 (0.3%) | 1 (0.3%) | 129 (40.4%) | 81 (25.4%) | ||
| Abrasion | 25 (7.8%) | 10 (3.1%) | 51 (16%) | 6 (1.9%) | ||
| Eczema | 8 (2.5%) | 5 (1.6%) | 20 (6.3%) | 12 (4%) | ||
| Allergic reaction | 3 (0.9%) | 2 (0.6%) | 24 (7.5%) | 18 (5.6%) | ||
| Others | 24 (7.5%) | 13 (4.1%) | 22 (6.9%) | 9 (2.8%) | ||
| Headache | 18 (5.6%) | 8 (2.5%) | 4 (1.3%) | — | ||
| Blurred vision | 6 (1.9%) | 4 (1.3%) | — | — | ||
| Giddy | 4 (1.3%) | — | 1 (0.3%) | — | ||
| Itchy | — | 1 (0.3%) | 10 (3.1%) | 4 (1.2%) | ||
| Eye pain | 1 (0.3%) | — | 1 | — | ||
| Difficulty in breathing | — | — | 3 (0.9%) | 2 (0.6%) | ||
| Throat irritation | — | — | 1 (0.3%) | — | ||
| Dry skin | — | — | 2 (0.6%) | 3 (0.9%) | ||
| Location | ||||||
| Nose bridge | 88 (27.6%) | 10 (3.1%) | 176 (55.2%) | 30 (9.4%) | 257.22 | <.001 |
| Cheeks | 63 (19.7%) | 8 (2.5%) | 170 (53.3%) | 70 (21.9%) | ||
| Forehead | 90 (28.2%) | 36 (11.3%) | 19 (6%) | 7 (2.2%) | ||
| Top of the ear | 35 (11.0%) | 14 (4.4%) | 76 (23.8%) | 16 (5.0%) | ||
| Behind the ear | 30 (9.4%) | 9 (2.8%) | 42 (13.2%) | 17 (5.3%) | ||
| Eyebrow arch (from wearing goggles) | 35 (11%) | — | — | — | ||
| Others | 8 (2.5%) | 7 (2.2%) | 38 (11.9%) | 35 (11.0%) | ||
Significant value p < .05.
Data expressed denotes multiple responses.
Chi‐square test.
PPE interference with patient treatment/nursing care (N = 592)
| Strongly agree | Agree | Neutral | Disagree | Strongly disagree | |
|---|---|---|---|---|---|
| PPE interferes with my ability to provide patient treatment and/or general nursing care | 22 (3.7%) | 95 (16%) | 246 (41.6%) | 168 (28.4%) | 61 (10.3%) |
| Long‐sleeved gowns interfere with my ability to provide patient treatment and/or general nursing care | 18 (3.0%) | 66 (11.1%) | 232 (39.2%) | 205 (34.6%) | 71 (12%) |
| Discomfort during nursing care | Yes | No | |||
| Do you experience discomfort wearing full PPE when providing patient treatment and/or general nursing care? | 163 (27.5%) | 429 (72.5%) | |||
| Types of discomfort experienced |
Glasses/goggles fogging causes poor vision Hot/warm, & sweaty/perspire Interferes with procedures (palpating veins, performing dressings, auscultation, delay in attending to patients, increases time to complete work) Difficulty in breathing Itch Pain from wearing PPE Heat rash Restricted movement | ||||
Participants' perceptions of PPE supply, training and reminders (N = 592)
| PPE supply |
Strongly Agree | Agree | Neutral | Disagree | Strongly disagree |
|---|---|---|---|---|---|
| Recommended PPE is readily available in the department? | 268 (45.3%) | 265 (44.8%) | 51 (8.6%) | 7 (1.2%) | 1 (0.2%) |
| Enough PPE supplies for all healthcare staff in the department? | 243 (41%) | 267 (45.1%) | 65 (11%) | 16 (2.7%) | 1 (0.2%) |
| Reminders and training | Strongly agree | Agree | Neutral | Disagree | Strongly disagree |
| Sufficient training in correct PPE use | 218 (36.8%) | 336 (56.8%) | 32 (5.4%) | 2 (0.3%) | 4 (0.7%) |
| Clear understanding of the indications for different types of PPE | 221 (37.3%) | 333 (56.3%) | 32 (5.4%) | 1 (0.2%) | 5 (0.8%) |
| Sufficient visual reminders about correct PPE Donning procedures | 203 (34.3%) | 331 (55.9%) | 46 (7.8%) | 6 (1.0%) | 6 (1.0%) |
| Sufficient visual reminders about correct PPE Doffing procedures | 197 (33.3%) | 321 (54.2%) | 60 (10.1%) | 7 (1.2%) | 7 (1.2%) |
| Visual reminders on Donning PPE are useful | 197 (33.3%) | 313 (52.9%) | 71 (12%) | 5 (0.8%) | 6 (1.0%) |
| Visual reminders on Doffing PPE are useful | 195 (32.9%) | 301 (50.8%) | 82 (13.9%) | 8 (1.4%) | 6 (1.0%) |
Perception of mask fitting and PPE protection, likelihood of exposure to COVID‐19 (N = 592)
| 0 not confident | 1 | 2 slight confident | 3 | 4 | 5 not sure | 6 | 7 | 8 very confident | 9 | 10 highly confident | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| PPE protection | 4 (0.7%) | 14 (2.4%) | 58 (9.8%) | 52 (8.8%) | 13 (2.2%) | 29 (4.9%) | 47 (7.9%) | 90 15.2%) | 180 (30.4%) | 23 (3.9%) | 81 (13.7%) |
| Confidence in N95 mask fit | 13 (2.0%) | 14 (2.4%) | 48 (8.1%) | 39 (6.6%) | 10 (1.7%) | 52 (8.8%) | 45 (7.6%) | 79 (13.3%) | 158 (26.7%) | 28 (4.7%) | 106 (17.9%) |
| Yes | No | Not applicable | |||||||||
| Are there any specific clinical procedures that increase your risk of exposure to COVID‐19 infection? | 138 (23.3%) | 272 (45.9%) | 182 (30.7%) | ||||||||
| Procedures identified as associated with increased risk of COVID‐19 exposure |
Airway procedures (intubation, suctioning, bronchoscopy, oropharyngeal examination, administering Bilevel Positive Airway Pressure ventilation and Performing COVID‐19 swab tests) Attending to suspected COVID‐19 patients Resuscitation Feeding (general) /Nasogastric feeding Performing venipuncture Violent/agitated patients (unable to put on full PPE on time) Unable to maintain safe distancing measures in clinics. | ||||||||||
| Daily | 2 to 3 times a week | Once a week | Not applicable | ||||||||
| How often do you perform clinical procedures that increase your exposure risk? | 152 (25.7%) | 86 (14.5%) | 87 (14.7%) | 231 (39%) | |||||||
Influence of PPE spotters on adherence to guidelines (N = 592)
| Yes | No | Not applicable | Not sure | |
|---|---|---|---|---|
| Are spotters used in clinical area to monitor donning and doffing PPE? | 269 (45.4%) | 63 (10.6%) | 52 (8.8%) | 208 (35.1%) |
| If Yes, Does the presence of ‘Spotters’ influence the way you use your PPE? | 95 (35.3%) | 153 (56.8%) | 21 (7.8%) | — |
| Examples of how PPE ‘Spotters’ influenced PPE practices |
Be more mindful Frequent remind staff proper donning and doffing PPE Increase awareness Prompt on doing hand rub Spotters are auditors Compliant to donning and doffing PPE | |||